The Capitol LedgerEvery move in Congress, on the record
HomeBillsRecordsLedger AI

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

AboutFAQFeedbackTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

The projectAboutFAQFeedback
LegalTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

All bills
S. 5498·119th Congress·Introduced Sep 24, 2026

Alpha-gal Allergen Inclusion Act

IntroducedHealthSubstantive
View bill text
Sponsor
Sen. Warner, Mark R. [D-VA]
Committees
Health, Education, Labor, and Pensions Committee (primary)
Last action
Sep 24, 2026

Bottom line

This bill mandates clear labeling for alpha-gal in food products, aiming to protect individuals with alpha-gal syndrome from accidental exposure.

What it actually does

This bill amends the Federal Food, Drug, and Cosmetic Act to classify galactose-alpha-1,3-galactose, commonly known as alpha-gal, as a "major food allergen." This classification mandates that food products containing alpha-gal, including derivatives from non-catarrhine primate mammals and red algae in the order Gigartinales, must be clearly labeled. However, it provides an exclusion for mammal-derived ingredients that the Secretary determines contain no alpha-gal above an established, detectable limit, such as those from alpha-gal-knockout mammals.

Proponents argue

Supporters argue that classifying alpha-gal as a major food allergen is crucial for public health, as it would provide essential information to individuals suffering from alpha-gal syndrome, allowing them to avoid potentially life-threatening allergic reactions. They emphasize that clear labeling empowers consumers and aligns with existing food safety standards for other major allergens, addressing a growing public health concern.

Opponents contend

Critics might argue that expanding the definition of "major food allergen" could impose significant new compliance burdens and costs on food manufacturers, particularly those using ingredients that might contain alpha-gal but are not traditionally considered allergens. They might also raise concerns about the scientific specificity of the definition or potential over-regulation if the prevalence or severity of alpha-gal reactions doesn't warrant such a broad classification.

The bill is very short and easy to read, allowing ample time for stakeholders to understand its provisions before the effective date.

Section 2(a)

Adding Alpha-gal to Definition of "Major Food Allergen"

prominently featuredstraightforward

This provision amends Section 201(qq) of the Federal Food, Drug, and Cosmetic Act to include "Galactose-alpha-1,3-galactose" (alpha-gal) in the list of major food allergens. This means that food products containing alpha-gal, including those derived from non-catarrhine primate mammals and red algae in the order Gigartinales, would be subject to mandatory labeling requirements, similar to allergens like peanuts or milk. However, it specifically excludes mammal-derived ingredients for which the Secretary determines there is no alpha-gal above an established, detectable limit, such as those from alpha-gal-knockout mammals.

GroupImpactMechanismScale
GroupIndividuals with alpha-gal syndromeImpactPositive (improved safety, easier avoidance of allergens)MechanismMandatory clear labeling on food products.ScaleAffects all individuals diagnosed with or susceptible to alpha-gal syndrome nationwide.
GroupFood manufacturers and producersImpactMixed (increased compliance burden, potential for new testing/sourcing requirements, but also clearer consumer information)MechanismNew labeling requirements for products containing alpha-gal.ScaleAffects all food manufacturers whose products may contain alpha-gal.

Supporters argue

Supporters argue that this provision is a critical public health measure, providing life-saving information to individuals with alpha-gal syndrome who currently face significant challenges in identifying safe foods. They contend that the clarity in labeling will prevent accidental exposures and improve the quality of life for those affected.

Critics contend

Opponents, particularly from the food industry, might argue that the broad definition of alpha-gal, including specific mammal and algae derivatives, could lead to overly burdensome and costly testing and labeling requirements. They may also contend that the scientific understanding of alpha-gal prevalence and thresholds for reaction is still evolving, making a broad mandate premature.

Tradeoffs

The provision balances the public health need for allergen information against potential compliance costs and complexities for the food industry. It also navigates the scientific challenge of defining alpha-gal sources and detectable limits while providing necessary consumer protection.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.

On this page

  • Executive summary
  • Key provisions
  • Follow the money
  • Critical analysis
  • Questions to ask
Ask Ledger AI about this